BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 24302456)

  • 21. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.
    Bauer TW; Liu W; Fan F; Camp ER; Yang A; Somcio RJ; Bucana CD; Callahan J; Parry GC; Evans DB; Boyd DD; Mazar AP; Ellis LM
    Cancer Res; 2005 Sep; 65(17):7775-81. PubMed ID: 16140945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene expression profile of metastatic human pancreatic cancer cells depends on the organ microenvironment.
    Nakamura T; Fidler IJ; Coombes KR
    Cancer Res; 2007 Jan; 67(1):139-48. PubMed ID: 17210693
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A perylene derivative regulates HIF-1α and Stat3 signaling pathways.
    Chen H; Guan Y; Yuan G; Zhang Q; Jing N
    Bioorg Med Chem; 2014 Feb; 22(4):1496-505. PubMed ID: 24485121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased expression of EIF5A2, via hypoxia or gene amplification, contributes to metastasis and angiogenesis of esophageal squamous cell carcinoma.
    Li Y; Fu L; Li JB; Qin Y; Zeng TT; Zhou J; Zeng ZL; Chen J; Cao TT; Ban X; Qian C; Cai Z; Xie D; Huang P; Guan XY
    Gastroenterology; 2014 Jun; 146(7):1701-13.e9. PubMed ID: 24561231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypoxia predicts aggressive growth and spontaneous metastasis formation from orthotopically grown primary xenografts of human pancreatic cancer.
    Chang Q; Jurisica I; Do T; Hedley DW
    Cancer Res; 2011 Apr; 71(8):3110-20. PubMed ID: 21343390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epigenetic regulation of SOX9 by the NF-κB signaling pathway in pancreatic cancer stem cells.
    Sun L; Mathews LA; Cabarcas SM; Zhang X; Yang A; Zhang Y; Young MR; Klarmann KD; Keller JR; Farrar WL
    Stem Cells; 2013 Aug; 31(8):1454-66. PubMed ID: 23592398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypoxia inducible factor (HIF)-1α directly activates leptin receptor (Ob-R) in pancreatic cancer cells.
    Ren H; Jia L; Zhao T; Zhang H; Chen J; Yang S; Liu J; Yu M; Hao J
    Cancer Lett; 2014 Nov; 354(1):172-80. PubMed ID: 25130171
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypoxia-inducible factor-2α promotes tumor progression and has crosstalk with Wnt/β-catenin signaling in pancreatic cancer.
    Zhang Q; Lou Y; Zhang J; Fu Q; Wei T; Sun X; Chen Q; Yang J; Bai X; Liang T
    Mol Cancer; 2017 Jul; 16(1):119. PubMed ID: 28705232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
    Chen MC; Lee CF; Huang WH; Chou TC
    Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypoxia inducible factor-1 mediates effects of insulin on pancreatic cancer cells and disturbs host energy homeostasis.
    Wang F; Li SS; Segersvärd R; Strömmer L; Sundqvist KG; Holgersson J; Permert J
    Am J Pathol; 2007 Feb; 170(2):469-77. PubMed ID: 17255315
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIF-1α is a crucial factor in the development of peritoneal dissemination via natural metastatic routes in scirrhous gastric cancer.
    Miyake S; Kitajima Y; Nakamura J; Kai K; Yanagihara K; Tanaka T; Hiraki M; Miyazaki K; Noshiro H
    Int J Oncol; 2013 Nov; 43(5):1431-40. PubMed ID: 23970191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Up-regulation of Krüppel-like factor 5 in pancreatic cancer is promoted by interleukin-1beta signaling and hypoxia-inducible factor-1alpha.
    Mori A; Moser C; Lang SA; Hackl C; Gottfried E; Kreutz M; Schlitt HJ; Geissler EK; Stoeltzing O
    Mol Cancer Res; 2009 Aug; 7(8):1390-8. PubMed ID: 19671674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutual regulation of hypoxic and retinoic acid related signalling in tubular proximal cells.
    Fernández-Martínez AB; Jiménez MI; Hernández IS; García-Bermejo ML; Manzano VM; Fraile EA; de Lucio-Cazaña FJ
    Int J Biochem Cell Biol; 2011 Aug; 43(8):1198-207. PubMed ID: 21554977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypoxia induces chondrocyte-specific gene expression in mesenchymal cells in association with transcriptional activation of Sox9.
    Robins JC; Akeno N; Mukherjee A; Dalal RR; Aronow BJ; Koopman P; Clemens TL
    Bone; 2005 Sep; 37(3):313-22. PubMed ID: 16023419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of the interplay between SOX9 and S100P in the metastasis and invasion of colon carcinoma.
    Shen Z; Deng H; Fang Y; Zhu X; Ye GT; Yan L; Liu H; Li G
    Oncotarget; 2015 Aug; 6(24):20672-84. PubMed ID: 26009899
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of YC-1 on hypoxia-inducible factor 1 alpha in hypoxic human bladder transitional carcinoma cell line T24 cells.
    Li Y; Zhao X; Tang H; Zhong Z; Zhang L; Xu R; Li S; Wang Y
    Urol Int; 2012; 88(1):95-101. PubMed ID: 22041818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular basis of the synergistic antiangiogenic activity of bevacizumab and mithramycin A.
    Jia Z; Zhang J; Wei D; Wang L; Yuan P; Le X; Li Q; Yao J; Xie K
    Cancer Res; 2007 May; 67(10):4878-85. PubMed ID: 17510417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypoxia induces CXCR4 expression and biological activity in gastric cancer cells through activation of hypoxia-inducible factor-1α.
    Oh YS; Kim HY; Song IC; Yun HJ; Jo DY; Kim S; Lee HJ
    Oncol Rep; 2012 Dec; 28(6):2239-46. PubMed ID: 23023480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypoxia-inducible factor-1alpha promotes nonhypoxia-mediated proliferation in colon cancer cells and xenografts.
    Dang DT; Chen F; Gardner LB; Cummins JM; Rago C; Bunz F; Kantsevoy SV; Dang LH
    Cancer Res; 2006 Feb; 66(3):1684-936. PubMed ID: 16452228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autocrine motility factor signaling enhances pancreatic cancer metastasis.
    Tsutsumi S; Yanagawa T; Shimura T; Kuwano H; Raz A
    Clin Cancer Res; 2004 Nov; 10(22):7775-84. PubMed ID: 15570012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.